纤维蛋白胶市场规模、份额和成长分析（按产品类型、技术、应用、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，全球纤维蛋白胶市场规模将达到 6.3915 亿美元，到 2025 年将达到 6.89 亿美元，到 2033 年将达到 12.5652 亿美元，预测期（2026-2033 年）的复合年增长率为 7.8%。

全球纤维蛋白胶市场的主要驱动因素是外科手术数量的增加，而这又受到人口老化导致慢性疾病（例如心血管疾病和整形外科疾病）患者需要手术治疗的影响。随着复杂手术的增多，人们对纤维蛋白胶纤维蛋白胶高效能止血剂的依赖性也日益增强。这是因为纤维蛋白密封剂能够快速形成稳定的血块，增强组织密封性，最终减少出血量并缩短恢復时间。市场的主要趋势包括生物技术和重组DNA技术的进步，这些技术促成了更安全、更有效的密封剂的研发，延长了其保质期并降低了免疫抗原性风险。改良的生产流程使得合成的、无病原体的产品成为可能，而创新的配方技术则提高了黏合性和聚合速度。这些因素正在扩大纤维蛋白胶在外科手术中的临床应用范围和接受度。

推动全球纤维蛋白胶市场发展的因素

全球外科手术量的增加是推动全球纤维蛋白胶市场扩张的主要因素。心臟病、癌症和整形外科疾病等慢性病的日益增多，促使人们在手术过程中需要使用纤维蛋白胶有效的止血解决方案。随着医疗机构寻求更先进的方案以改善患者预后并提高手术效率，对可靠且高效的手术器械日益增长的需求，在推动市场发展方面发挥关键作用。因此，对创新医疗解决方案的日益关注，进一步刺激了市场动态。

限制全球纤维蛋白胶市场的因素

全球纤维蛋白胶市场的成长受到监管挑战和漫长核准流程的限制。在不同地区进行全面的临床试验并遵守监管标准，延长了产品研发週期，从而限制了新产品的上市。这种情况可能会阻碍尖端纤维蛋白胶解决方案的广泛应用，最终影响该行业的市场动态和创新。儘管企业正在努力克服这些障碍，但及时获得先进产品仍受到限制，这影响了寻求有效伤口管理方案的製造商和消费者。

全球纤维蛋白胶市场趋势

受微创手术技术需求不断增长的推动，全球纤维蛋白胶市场正经历显着成长。随着医疗机构致力于改善患者预后，纤维蛋白胶因其有助于缩短恢復时间、减少出血量和提升整体手术效果而日益受到认可。其广泛的应用，尤其是在心血管和整形外科手术领域，证实了其在精准度和快速恢復至关重要的手术中发挥的关键作用。这种不断增长的需求不仅标誌着外科手术实践的变革，也预示着一种趋势，即采用能够促进有效癒合和提升患者福祉的尖端材料。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球纤维蛋白胶市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 液体
  • 冷冻纤维蛋白胶
  • 冷冻纤维蛋白胶
• 修补
• 粉末
• 其他的

全球纤维蛋白胶市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 病毒灭活
• 自体输血
• 重组生产
• 其他的

全球纤维蛋白胶市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 整形外科手术
• 心血管外科
• 一般外科
• 移植手术
• 其他的

全球纤维蛋白胶市场规模（以最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 专科诊所
• 其他的

全球纤维蛋白胶市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Baxter International（USA）
• CSL Limited（Australia）
• Vivostat A/S（Denmark）
• Grifols, SA（Spain）
• Pfizer Inc.（USA）
• Stryker Corporation（USA）
• Hemarus（Australia）
• Asahi Kasei Corporation（Japan）
• Z-Medica（USA）
• Marquee Biosurgical（USA）
• Hualan Biological Engineering（China）
• CryoLife, Inc.（USA）
• Integra LifeSciences Corporation（USA）
• Becton, Dickinson and Company（USA）
• B. Braun SE（Germany）
• Corza Medical（USA/Switzerland）
• Cohera Medical（USA）
• Advanced Medical Solutions Group plc（UK）
• Ocular Therapeutix, Inc.（USA）
• MicroVal（France）

结论与建议

Global Fibrin Sealants Market size was valued at USD 639.15 Million in 2024 and is poised to grow from USD 689 Million in 2025 to USD 1256.52 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global fibrin sealants market is primarily driven by the increasing volume of surgical procedures, influenced by an aging population prone to chronic illnesses that necessitate surgery, including cardiovascular and orthopedic conditions. As complex surgeries rise, the reliance on effective hemostatic agents like fibrin sealants grows due to their ability to quickly form stable clots and enhance tissue sealing, ultimately reducing blood loss and recovery times. A significant trend within the market is the advancement of biologic and recombinant DNA technologies, yielding safer and more effective sealants with longer shelf lives and lower immunogenic risks. Enhanced manufacturing processes enable the creation of synthetic, pathogen-free products, while innovative formulations improve adhesion and polymerization speed, thereby broadening the clinical use and acceptance of fibrin sealants in surgical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fibrin Sealants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fibrin Sealants Market Segments Analysis

Global Fibrin Sealants Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Liquid, Patches, Powder and Others. Based on Technology, the market is segmented into Viral Inactivation, Autologous Donation, Recombinant Production and Others. Based on Application, the market is segmented into Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fibrin Sealants Market

The increasing prevalence of surgical interventions across the globe serves as a major catalyst for the expansion of the global fibrin sealants market. A rise in chronic health conditions, such as heart diseases, cancer, and orthopedic issues, boosts the demand for effective hemostatic solutions, like fibrin sealants, during surgical procedures. This heightened need for reliable and efficient surgical tools plays a crucial role in propelling market development, as healthcare providers seek advanced options to improve patient outcomes and enhance the efficiency of operations. Consequently, the growing emphasis on innovative medical solutions further stimulates market dynamics.

Restraints in the Global Fibrin Sealants Market

The growth of the global fibrin sealants market is hindered by regulatory challenges and protracted approval procedures for these products. The requirement for comprehensive clinical trials and adherence to regulatory standards across various regions extends development timelines, which in turn restricts the introduction of new products into the market. This situation may discourage the availability of cutting-edge fibrin sealant solutions, ultimately affecting the overall market dynamics and innovation in the field. As companies navigate these obstacles, the potential for timely access to advanced offerings remains constrained, impacting both manufacturers and consumers seeking effective wound management options.

Market Trends of the Global Fibrin Sealants Market

The Global Fibrin Sealants market is witnessing a significant uptick fueled by the escalating preference for minimally invasive surgical techniques. As healthcare providers aim to enhance patient outcomes, fibrin sealants are increasingly recognized for their capacity to facilitate quicker recovery times, minimize blood loss, and improve overall surgical results. Their versatility in applications, especially within the fields of cardiovascular and orthopedics, underscores their critical role in procedures where precision and rapid recovery are paramount. This growing demand not only highlights a shift in surgical practices but also signals a broader trend towards advanced materials that support effective healing and patient wellbeing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fibrin Sealants Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Liquid
  • Frozen fibrin sealants
  • Freeze dried fibrin sealants
• Patches
• Powder
• Others

Global Fibrin Sealants Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Viral Inactivation
• Autologous Donation
• Recombinant Production
• Others

Global Fibrin Sealants Market Size by Application & CAGR (2026-2033)

• Market Overview
• Orthopedic Surgery
• Cardiovascular surgery
• General Surgery
• Transplant Surgery
• Others

Global Fibrin Sealants Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Fibrin Sealants Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivostat A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemarus (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z-Medica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marquee Biosurgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Medical (USA/Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Therapeutix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVal (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations